|
|
||||||||
The Annals of Thoracic Surgery, Vol 52, 993-999, Copyright © 1991 by The Society of Thoracic Surgeons
EJ Baker 5th, GN Olinger and JE Baker
Clinical application of hypothermic pharmacologic cardioplegia in pediatric
cardiac surgery is less than satisfactory, despite its well known benefits
in adults. Protection of the ischemic immature rabbit heart with
hypothermia alone is better than with hypothermic St. Thomas' II
cardioplegic solution. Control of cellular calcium is a critical component
of cardioplegic protection. We determined whether the existing calcium
content of St. Thomas' II solution (1.2 mmol/L) is responsible for
suboptimal protection of the ischemic immature rabbit heart. Modified
hypothermic St. Thomas' II solutions (calcium content, 0 to 2.4 mmol/L)
were compared with hypothermic Krebs bicarbonate buffer in protecting
ischemic immature (7- to 10-day-old) hearts. Hearts (n = 6 per group)
underwent aerobic "working" perfusion with Krebs buffer, and cardiac
function was measured. The hearts were then arrested with a 3-minute
infusion of either cold (14 degrees C) Krebs buffer (1.8 mmol calcium/L) as
hypothermia alone or cold St. Thomas' II solution before 6 hours of
hypothermic (14 degrees C) global ischemia. Hearts were reperfused, and
postischemic enzyme leakage and recovery of function were measured. A
bell-shaped dose-response profile for calcium was observed for recovery of
aortic flow but not for creatine kinase leakage, with improved protection
at lower calcium concentrations. Optimal myocardial protection occurred at
a calcium content of 0.3 mmol/L, which was better than with hypothermia
alone and standard St. Thomas' II solution. We conclude that the existing
calcium content of St. Thomas' II solution is responsible, in part, for its
damaging effect on the ischemic immature rabbit heart.
ARTICLES
Calcium content of St. Thomas' II cardioplegic solution damages ischemic immature myocardium
Department of Cardiothoracic Surgery, Medical College of Wisconsin, Milwaukee 53226.
This article has been cited by other articles:
![]() |
T. Doenst, C. Schlensak, and F. Beyersdorf Cardioplegia in pediatric cardiac surgery: do we believe in magic? Ann. Thorac. Surg., May 1, 2003; 75(5): 1668 - 1677. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. D. Buckberg Cardioplegic solutions: Unproved herbal approach versus tested scientificstudy J. Thorac. Cardiovasc. Surg., November 1, 1999; 118(5): 975 - 977. [Full Text] [PDF] |
||||
![]() |
J. N. Young, I. O. Choy, N. K. Silva, D. Y. Obayashi, and H. E. Barkan ANTEGRADE COLD BLOOD CARDIOPLEGIA IS NOT DEMONSTRABLY ADVANTAGEOUS OVER COLD CRYSTALLOID CARDIOPLEGIA IN SURGERY FOR CONGENITAL HEART DISEASE J. Thorac. Cardiovasc. Surg., December 1, 1997; 114(6): 1002 - 1009. [Abstract] [Full Text] |
||||
![]() |
J. E. Baker and G. N. Olinger Myocardial protection of the hypoxic heart J. Thorac. Cardiovasc. Surg., June 1, 1997; 113(6): 1123 - 1124. [Full Text] |
||||
![]() |
R. H. Chen The Scientific Basis for Hypocalcemic Cardioplegia and Reperfusion in Cardiac Surgery Ann. Thorac. Surg., September 1, 1996; 62(3): 910 - 914. [Abstract] [Full Text] |
||||
![]() |
M. Karck, G. Ziemer, M. Zoeller, S. Schulte, K.-D. Juergens, H. Weisser, and A. Haverich Protection of the Chronic Hypoxic Immature Rat Heart During Global Ischemia Ann. Thorac. Surg., March 1, 1995; 59(3): 699 - 706. [Abstract] [Full Text] |
||||
![]() |
L. J. Kohman and L. J. Veit Single-dose versus multidose cardioplegia in neonatal hearts J. Thorac. Cardiovasc. Surg., June 1, 1994; 107(6): 1512 - 1518. [Abstract] [Full Text] |
||||
![]() |
M. Aoki, F. Nomura, and J. E. Mayer Jr. Interactions between preischemic hypothermia and cardioplegic solutions in the neonatal lamb heart J. Thorac. Cardiovasc. Surg., March 1, 1994; 107(3): 822 - 828. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |